(Q41255441)

28 September 2017

1 reference

title

Moving towards better predictors of drug-induced torsades de pointes (English)

1 reference

28 September 2017

A S Bass

1

1 reference

28 September 2017

B Darpo

2

1 reference

28 September 2017

J-P Valentin

3

1 reference

28 September 2017

P Sager

4

1 reference

28 September 2017

K Thomas

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

23 June 2008

1 reference

British Journal of Pharmacology

28 September 2017

1 reference

28 September 2017

154

1 reference

28 September 2017

7

1 reference

28 September 2017

1550-1553

1 reference

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Risk assessment in drug development for symptomatic indications: a framework for the prospective exclusion of unacceptable cardiovascular risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Cardiotoxicity of new antihistamines and cisapride

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Risk of selected serious cardiac events among new users of antihistamines

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492097

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability

19 August 2018

1 reference

12 December 2020

Drug-induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity

1 reference

12 December 2020

QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans

1 reference

12 December 2020

The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada

1 reference

12 December 2020

Drug-induced prolongation of the QT interval: why the regulatory concern?

1 reference

12 December 2020

Cardiac arrhythmias reported during treatment with cisapride

1 reference

12 December 2020

The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspective

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJP.2008.215

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BJP.2008.215

1 reference

28 September 2017

1 reference

28 September 2017

PubMed publication ID

18574462

1 reference